WASHINGTON, Feb. 27, 2021 /PRNewswire/ -- Statement from
Scott J. Knoer, MS, PharmD, FASHP,
executive vice president and CEO of the American Pharmacists
Association, upon the Food and Drug Administration's (FDA) decision
today to authorize emergency use of Janssen Biotech's COVID-19
vaccine:
"Since the first COVID-19 vaccines were authorized more than two
months ago, hundreds of thousands of trained and trusted
pharmacists, student pharmacists and pharmacy technicians have been
willing, ready and able to administer the vaccine to individuals
across the country. With this newly authorized COVID vaccine, in
addition to the growing supply of currently authorized vaccines,
more pharmacists will be able to do their part as vaccinators and
vital members of the immunization neighborhood, thereby increasing
access to these vital tools.
"We welcome the FDA's authorization of the Janssen vaccine. The
addition of another safe and effective vaccine to our toolbox means
that we are another step closer to our goal of vaccinating everyone
we can as quickly as possible, and controlling this terrible
pandemic."
About the American Pharmacists Association
The
American Pharmacists Association is the largest association of
pharmacists in the United States
advancing the entire pharmacy profession. Our expert staff, and
strong volunteer leadership, including many experienced
pharmacists, allow us to deliver vital leadership to help
pharmacists, pharmaceutical scientists, student pharmacists and
pharmacy technicians find success and satisfaction in their work,
while advocating for changes that benefit them, their patients and
communities. For more information, please
visit www.pharmacist.com.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/american-pharmacists-association-comment-on-authorization-of-janssen-vaccine-we-are-ready-to-continue-this-work-301236876.html
SOURCE American Pharmacists Association